J
5.50
-0.18 (-3.17%)
| Penutupan Terdahulu | 5.68 |
| Buka | 5.62 |
| Jumlah Dagangan | 175,039 |
| Purata Dagangan (3B) | 205,771 |
| Modal Pasaran | 82,621,552 |
| Harga / Buku (P/B) | 1.18 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Aug 2025 - 15 Aug 2025 |
| EPS Cair (TTM) | -5.27 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.13% |
| Nisbah Semasa (MRQ) | 4.31 |
| Aliran Tunai Operasi (OCF TTM) | -69.71 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -43.72 M |
| Pulangan Atas Aset (ROA TTM) | -56.50% |
| Pulangan Atas Ekuiti (ROE TTM) | -101.34% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | Jasper Therapeutics, Inc. | Menurun | Menurun |
AISkor Stockmoo
-1.3
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.25 |
|
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.27% |
| % Dimiliki oleh Institusi | 87.94% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Qiming U.S. Ventures Management, Llc | 31 Mar 2025 | 928,964 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 65.00 (Oppenheimer, 1,081.82%) | Beli |
| Median | 20.00 (263.64%) | |
| Rendah | 4.00 (BMO Capital, -27.27%) | Pegang |
| Purata | 24.86 (352.00%) | |
| Jumlah | 6 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 3.55 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BMO Capital | 08 Jul 2025 | 4.00 (-27.27%) | Pegang | 3.02 |
| Evercore ISI Group | 08 Jul 2025 | 20.00 (263.64%) | Beli | 3.02 |
| JMP Securities | 08 Jul 2025 | 12.00 (118.18%) | Beli | 3.02 |
| BTIG | 07 Jul 2025 | 20.00 (263.64%) | Beli | 3.04 |
| HC Wainwright & Co. | 07 Jul 2025 | 20.00 (263.64%) | Beli | 3.04 |
| Oppenheimer | 15 May 2025 | 65.00 (1,081.82%) | Beli | 4.87 |
| UBS | 13 May 2025 | 33.00 (500.00%) | Beli | 4.82 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 09 Jul 2025 | Pengumuman | Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway |
| 07 Jul 2025 | Pengumuman | Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria |
| 14 Jun 2025 | Pengumuman | Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria |
| 03 Jun 2025 | Pengumuman | Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress |
| 14 May 2025 | Pengumuman | Jasper Therapeutics to Present at Upcoming Investor Conferences |
| 12 May 2025 | Pengumuman | Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |